Osteoarthritis and Bone Disorders News

Addressing the racial disparities that continue to plague health care requires “continuous” work, as well as holding certain providers’ “feet to the fire,” said a presenter at the 2022 Association of Women in Rheumatology annual conference.

A denosumab biosimilar candidate demonstrated noninferior efficacy to its reference product, with similar safety profile, in postmenopausal patients with osteoporosis, according to data published in Arthritis Research & Therapy.

Even modest osteoarthritis pain reductions through intervention would substantially reduce the number of knee replacements, according to data published in Arthritis & Rheumatology.

ORLANDO — Exercise can supplement the efficacy of several therapies used to treat osteoporosis, according to a presenter at the 2022 Rheumatology Nurses Society Annual Conference.

Denosumab is associated with a greater increase in lumbar spine bone mineral density at 12 months compared with ibandronate as a sequential treatment after 12 months of romosozumab therapy, according to study findings published in Bone.

Vitamin D3 supplementation is not associated with a reduced risk for fractures among healthy middle-aged and older adults, according to study results published in The New England Journal of Medicine.

Among South-East Asian adults, bisphosphonate use in is not associated with differences in clinical outcomes or mortality after an atypical femur fracture, according to study data published in Bone.

Teriparatide restores bone mineral quality to premenopausal levels for women with postmenopausal osteoporosis if taken for 24 months, but not if taken at shorter intervals, according to study findings published in Bone.

In a study spanning 24 months, higher levels of vitamin K intake appeared to correspond with decreased knee symptoms in patients with osteoarthritis, according to data published in Arthritis Care & Research.

Consuming specific dietary components such as vitamin D or omega-3 is “unlikely to influence the progression” of rheumatic and musculoskeletal diseases, according to a report of systemic reviews published in RMD Open.